Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Digital capability widened

8 May 2009 14:55

RNS Number : 9610R
Cello Group plc
08 May 2009
 



8 May 2009

Cello Group plc

Digital capability widened with increased holding in Face Group

 

Cello Group plc ("Cello" or the "Group", AIM: CLL), the leading independent market research and consulting group, has acquired an additional 30.6% in Fenix Media Limited ("Fenix Media"), taking its total holding to 50.7%. The original stake was acquired in December 2007. 

Fenix Media trades under the name Face Group (http://www.facegroup.co.uk) and has a number of leading edge digital research and co-creation products.

Mark Scott, Cello Chief Executive, commented:

"Taking a majority stake in Face Group is another important step in widening our digital capabilities. The products and services offered by Face Group are increasingly in demand from our growing range of global blue chip client base."

The Group will issue 443,792 new ordinary shares of 10p each ("Ordinary Shares") pursuant to the share purchase agreement with the vendors of Fenix Media. Application has been made for the Ordinary Shares to be admitted to trading on AIM and admission is expected to occur on 13 May 2009. The Ordinary Shares are subject to a full trading lock-in for a year and a sliding lock-in for the following two years. 

The Group has now settled all of the earn out and related liabilities that were detailed in the results announcement of 17 March 2009 as being due for settlement within one year. 

The Group's issued share capital, following this issue of 443,792 new ordinary shares will be 58,762,197 Ordinary Shares. The new Ordinary Shares will rank from admission pari passu in all respects with the existing Ordinary Shares in issue. The Group holds 237,000 Ordinary Shares in treasury at the date of this announcement. The total number of current voting rights in the Group will therefore be 58,525,197 shares.

The above figure (58,525,197 Ordinary Shares) may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Group under the FSA's Disclosure and Transparency Rules. 

Enquiries

 

Cello Group 

 

Mark Scott, Chief Executive

020 7812 8460

Mark Bentley, Finance Director

 

Singer Capital Markets

 

Nicholas How

020 3205 7620

 

 

College Hill

 

Adrian Duffield/Rozi Morris

020 7457 2020

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUWVORKORVRAR
Date   Source Headline
5th Jun 20181:24 pmRNSBlock listing Interim Review
29th May 20183:45 pmRNSDirector/PDMR Dealings and Total Voting Rights
9th May 20181:14 pmRNSResult of AGM
9th May 20187:00 amRNSAGM Statement
30th Apr 20182:58 pmRNSTotal Voting Rights
26th Apr 20189:45 amRNSChange of Name
25th Apr 20184:45 pmRNSChange of Name update
23rd Apr 201810:28 amRNSChange of name to Cello Health Group plc
16th Apr 20189:30 amRNSAnnual Report and Notice of AGM
22nd Mar 20187:00 amRNSFinal Results
27th Feb 20183:38 pmRNSTotal Voting Rights
18th Jan 20187:00 amRNSPre Close Trading Statement
23rd Nov 20173:54 pmRNSHolding(s) in Company
31st Oct 201711:16 amRNSTotal Voting Rights
26th Oct 20172:37 pmRNSDirector/PDMR Shareholding
29th Sep 20173:43 pmRNSGrant of Options
27th Sep 20174:59 pmRNSDirector/PDMR Shareholding
22nd Sep 201712:05 pmRNSDirector/PDMR Shareholding
20th Sep 20173:58 pmRNSHolding(s) in Company
20th Sep 201711:52 amRNSAdditional Block Listing of Ordinary Shares
20th Sep 20177:00 amRNSInterim Results
31st Aug 20173:19 pmRNSTotal Voting Rights
31st Jul 20173:06 pmRNSTotal Voting Rights
19th Jul 20177:00 amRNSPre Close Trading Statement
18th Jul 20177:00 amRNSAcquisition of Advantage Healthcare Inc
30th Jun 201712:31 pmRNSTotal Voting Rights
23rd Jun 201712:23 pmRNSHolding(s) in Company
14th Jun 201711:33 amRNSDirector/PDMR Shareholding
31st May 201710:27 amRNSTotal Voting Rights
18th May 20172:13 pmRNSHolding(s) in Company
10th May 20175:18 pmRNSHolding(s) in Company
9th May 20172:55 pmRNSResult of AGM
9th May 20177:00 amRNSAGM Statement
2nd May 20173:15 pmRNSIssue of Equity
13th Apr 20172:40 pmRNSAnnual Report and notice of Annual General Meeting
4th Apr 20175:44 pmRNSBlock listing Interim Review
31st Mar 201710:43 amRNSTotal Voting Rights
28th Mar 20173:03 pmRNSHolding(s) in Company
22nd Mar 20177:00 amRNSPreliminary Results
21st Feb 20171:30 pmRNSHolding(s) in Company
20th Feb 20173:19 pmRNSHolding(s) in Company
20th Feb 20179:29 amRNSTotal Voting Rights
17th Feb 201710:40 amRNSResult of General Meeting
1st Feb 20177:00 amRNSPlacing & Acquisition of Defined Health
19th Jan 20177:00 amRNSPre close trading statement
31st Oct 20163:58 pmRNSTotal Voting Rights
28th Oct 201611:37 amRNSDirector/PDMR Shareholding
12th Oct 20167:00 amRNSDirectorate Change
5th Oct 20164:32 pmRNSDirector/PDMR Shareholding
23rd Sep 20165:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.